|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. 67:7–30. 2017.
|
|
2
|
Wu K, Xu K, Liu K, Huang J, Chen J, Zhang
J and Zhang N: Long noncoding RNA BC200 regulates cell growth and
invasion in colon cancer. Int J Biochem Cell Biol. 99:219–225.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mody K and Bekaii-Saab T: Clinical trials
and progress in metastatic colon cancer. Surg Oncol Clin N Am.
27:349–365. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Deng H, Wang JM, Li M, Tang R, Tang K, Su
Y, Hou Y and Zhang J: Long non-coding RNAs: New biomarkers for
prognosis and diagnosis of colon cancer. Tumour Biol.
39:10104283177063322017. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hankey W, Frankel WL and Groden J:
Functions of the APC tumor suppressor protein dependent and
independent of canonical WNT signaling: Implications for
therapeutic targeting. Cancer Metastasis Rev. 37:159–172. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Raskov H, Pommergaard HC, Burcharth J and
Rosenberg J: cColorectal carcinogenesis-update and perspectives.
World J Gastroenterol. 20:18151–18164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Malhotra P, Anwar M, Nanda N, Kochhar R,
Wig JD, Vaiphei K and Mahmood S: Alterations in K-ras, APC and
p53-multiple genetic pathway in colorectal cancer among Indians.
Tumour Biol. 34:1901–1911. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hammoudi A, Song F, Reed KR, Jenkins RE,
Meniel VS, Watson AJ, Pritchard DM, Clarke AR and Jenkins JR:
Proteomic profiling of a mouse model of acute intestinal Apc
deletion leads to identification of potential novel biomarkers of
human colorectal cancer (CRC). Biochem Biophys Res Commun.
440:364–370. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jeong D, Heo S, Sung Ahn T, Lee S, Park S,
Kim H, Park D, Byung Bae S, Lee SS, Soo Lee M, et al: Cyr61
expression is associated with prognosis in patients with colorectal
cancer. BMC Cancer. 14:1642014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li X, Yang C, Wang X, Zhang J, Zhang R and
Liu R: The expression of miR-25 is increased in colorectal cancer
and is associated with patient prognosis. Med Oncol. 31:7812014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lin PL, Wu DW, Huang CC, He TY, Chou MC,
Sheu GT and Lee H: MicroRNA-21 promotes tumour malignancy via
increased nuclear translocation of β-catenin and predicts poor
outcome in APC-mutated but not in APC-wild-type colorectal cancer.
Carcinogenesis. 35:2175–2182. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Johnson SM, Grosshans H, Shingara J, Byrom
M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D and Slack
FJ: RAS is regulated by the let-7 microRNA family. Cell.
120:635–647. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hansen TF, Christensen Rd, Andersen RF,
Sørensen FB, Johnsson A and Jakobsen A: MicroRNA-126 and epidermal
growth factor-like domain 7-an angiogenic couple of importance in
metastatic colorectal cancer. Results from the Nordic ACT trial. Br
J Cancer. 109:1243–1251. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chandrashekar DS, Bashel B, Balasubramanya
SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B and Varambally
S: UALCAN: A portal for facilitating tumor subgroup gene expression
and survival analyses. Neoplasia. 19:649–658. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Prevostel C and Blache P: The
dose-dependent effect of SOX9 and its incidence in colorectal
cancer. Eur J Cancer. 86:150–157. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Malla RR, Pandrangi S, Kumari S, Gavara MM
and Badana AK: Exosomal tetraspanins as regulators of cancer
progression and metastasis and novel diagnostic markers. Asia Pac J
Clin Oncol. 14:383–391. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kumara HMCS, Bellini GA, Caballero OL,
Herath SAC, Su T, Ahmed A, Njoh L, Cekic V and Whelan RL:
P-Cadherin (CDH3) is overexpressed in colorectal tumors and has
potential as a serum marker for colorectal cancer monitoring.
Oncoscience. 4:139–147. 2017.PubMed/NCBI
|
|
19
|
Hibi K, Goto T, Mizukami H, Kitamura YH,
Sakuraba K, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and
Sanada Y: Demethylation of the CDH3 gene is frequently detected in
advanced colorectal cancer. Anticancer Res. 29:2215–2217.
2009.PubMed/NCBI
|
|
20
|
Hibi K, Kitamura YH, Mizukami H, Goto T,
Sakuraba K, Sakata M, Saito M, Ishibashi K, Kigawa G, Nemoto H and
Sanada Y: Frequent CDH3 demethylation in advanced gastric
carcinoma. Anticancer Res. 29:3945–3947. 2009.PubMed/NCBI
|
|
21
|
Kim TH, Chang JH, Lee HJ, Kim JA, Lim YS,
Kim CW and Han SW: mRNA expression of CDH3, IGF2BP3 and BIRC5 in
biliary brush cytology specimens is a useful adjunctive tool of
cytology for the diagnosis of malignant biliary stricture. Medicine
(Baltimore). 95:e41322016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yi S, Yang ZL, Miao X, Zou Q, Li J, Liang
L, Zeng G and Chen S: N-cadherin and P-cadherin are biomarkers for
invasion, metastasis and poor prognosis of gallbladder carcinomas.
Pathol Res Pract. 210:363–368. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang Z, Ghoorun RA, Fan X, Wu P, Bai Y, Li
J, Chen H, Wang L and Wang J: High expression of Beclin-1 predicts
favorable prognosis for patients with colorectal cancer. Clin Res
Hepatol Gastroenterol. 39:98–106. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bujko M, Kober P, Mikula M, Ligaj M,
Ostrowski J and Siedlecki JA: Expression changes of cell-cell
adhesion-related genes in colorectal tumors. Oncol Lett.
9:2463–2470. 2015. View Article : Google Scholar : PubMed/NCBI
|
